Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 4/20 | 0.46 |
| ▸ | NOS3 | P29474 | 1/20 | 0.46 |
| ▸ | NOS1 | P29475 | 1/20 | 0.46 |
| ▸ | NOS2 | P35228 | 1/20 | 0.46 |
| ▸ | MAOB | P27338 | 1/20 | 0.46 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | CTSL | P07711 | 1/20 | 0.43 |
| ▸ | CTSB | P07858 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1255779 | 0.94 | IDO1 (0.46) | IDO1NOS3NOS1NOS2MAOB | |
| SCHEMBL6916072 | 0.92 | IDO1 (0.44) | IDO1NOS3NOS1NOS2MAOB | |
| SCHEMBL11853076 | 0.92 | IDO1 (0.44) | IDO1NOS3NOS1NOS2MAOB | |
| SCHEMBL1255808 | 0.92 | IDO1 (0.44) | IDO1NOS3NOS1NOS2MAOB | |
| SCHEMBL13610289 | 0.88 | TP53 (0.44) | IDO1NOS3NOS1NOS2MAOB | |
| Dibenzyl Disulfide SCHEMBL16332737 | 0.88 | HSD17B10 (0.52) | IDO1NOS3NOS1NOS2MAOB | |
| Dibenzyl Disulfide SCHEMBL160895 | 0.88 | HSD17B10 (0.52) | IDO1NOS3NOS1NOS2MAOB | |
| SCHEMBL4276285 | 0.86 | L3MBTL1 (0.53) | IDO1CTSBCYP1A2CYP3A4CYP2D6 | |
| Dibenzyl Disulfide SCHEMBL32679343 | 0.85 | HSD17B10 (0.50) | IDO1NOS3NOS1NOS2MAOB | |
| Dibenzyl Disulfide SCHEMBL28928181 | 0.85 | ALDH1A1 (0.50) | IDO1NOS3NOS1NOS2MAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7622507-B2 | Substituted organosulfur compounds and methods of using thereof | ACEA BIOSCIENCES INC. (US) | 2009-11-24 | — | — | US | claimed |
| EP-1742635-A2 | SUBSTITUTED ORGANOSULFUR COMPOUNDS AND METHODS OF USING THEREOF | Acea Biosciences, Inc. (US) | 2007-01-17 | — | — | EP | claimed |
| WO-2005112933-A2 | SUBSTITUTED ORGANOSULFUR COMPOUNDS AND METHODS OF USING THEREOF | ACEA BIOSCIENCES INC. (US) | 2005-12-01 | — | — | WO | claimed |
| US-20050261321-A1 | Substituted organosulfur compounds and methods of using thereof | ACEA Therapeutics, Inc. | 2005-11-24 | — | — | US | claimed |
| JP-1180821-A | — | — | None | — | — | JP | disclosed |
| CN-119632039-B | Application of organic bistrifluoro in promoting plant growth and plant growth promoter | 天津天开瑞来有限公司 | 2025-06-17 | — | — | CN | disclosed |
| CN-119632039-A | Application of organic bistrifluoro in promoting plant growth and plant growth promoter | 天津天开瑞来有限公司 | 2025-03-18 | — | — | CN | disclosed |
| CN-118556042-A | Organic dithio compound and application thereof | 惠州市银农科技股份有限公司 | 2024-08-27 | — | — | CN | disclosed |
| CN-118253343-A | Synthesis method of symmetrical trisulfide compound and high-efficiency catalyst used by same | 常州大学 | 2024-06-28 | — | — | CN | disclosed |
| WO-2024125489-A1 | ORGANIC TRISULFIDE COMPOUND AND USE THEREOF | 惠州市银农科技股份有限公司 | 2024-06-20 | — | — | WO | disclosed |
| CN-115819302-B | Organic dithio-trisulfide compound and application thereof in plant bacteriostasis | 惠州市银农科技股份有限公司 | 2024-05-24 | — | — | CN | disclosed |
| CN-117003676-A | Method for catalytic synthesis of symmetrical dialkyl disulfide | 辽宁石油化工大学 | 2023-11-07 | — | — | CN | disclosed |
| EP-0909797-A1 | Stabilizers for vinyl ether-based coating systems | AlliedSignal Inc. (US) | 1999-04-21 | — | — | EP | disclosed |
| US-5491178-A | STABILIZING, INHIBITING THE DEHYDROGENATION BY APPLYING A COATING MIXTURE COMPRISING HINDERED PHENOLS, ORGANIC SULFIDES OR DISULFIDES AND TRANSITION METAL SALTS OR COMPLEXES | ALLIEDSIGNAL INC. (US) | 1996-02-13 | — | — | US | disclosed |
| WO-1995029126-A1 | A METHOD FOR MAKING MOLYBDENUM AND SULFUR CONTAINING COMPOUNDS | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1995-11-02 | — | — | WO | disclosed |
| US-5342531-A | Polyalkylene glycol lubricant compositions | ETHYL PETROLEUM ADDITIVES LIMITED (GB) | 1994-08-30 | — | — | US | disclosed |
| US-5300274-A | Method for making molybdenum and sulfur containing compounds | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1994-04-05 | — | — | US | disclosed |
| EP-0460317-B1 | Polyalkylene glycol lubricant compositions | ETHYL PETROLEUM ADDITIVES LTD (GB) | 1993-10-20 | — | — | EP | disclosed |
| EP-0460317-A1 | Polyalkylene glycol lubricant compositions | ETHYL PETROLEUM ADDITIVES LIMITED (GB) | 1991-12-11 | — | — | EP | disclosed |
| JP-H01180821-A | TREATING AND PREVENTING AGENT FOR LIVER DISEASE | EISAI CO LTD | 1989-07-18 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050261321-A1 | Substituted organosulfur compounds and methods of using thereof | TST, CTH, CBS | IDO1 1114/4885NOS3 814/4885NOS1 1621/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.